A good CRO to learn, but slow career progression - Recensione dipendente - Biostatistician presso IQVIA

3,0
18 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Strong brand and stability in healthcare/data, which looks good on a CV and supports career mobility. Often good work‑life balance and remote/flexible options in many teams, especially for non‑field roles. Interesting, large‑scale data and international projects that can deepen technical and domain expertise. Decent overall benefits and supportive coworkers in many units, even if pay is not top‑tier.

Svantaggi

Promotions and pay increases are often slow or modest, leading to frustration once you’re past early‑career stages. Resourcing and workload can be uneven: some teams are understaffed and high‑pressure, especially during peak periods. Management and culture vary heavily by manager and project; “good manager vs bad manager” can define the whole experience. Internal growth and visibility can feel opaque, with some employees reporting poor HR processes and limited long‑term progression.

Esplora altre recensioni su IQVIA

5,0
5 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Work life balance was good

Svantaggi

Limited opportunities for PM advancement

4,0
9 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Tremendous data assets and people subject matter expertise. Great assistance in providing employees with learning new skills and career growth. The company embraces workers with deep experience

Svantaggi

A lot of confusion and competition on who engages clients and who gets credit for sales. Clients are often confused on who is the point of contact .

Vedi recensioni per: Utile|Valutazione|Data|Tutto